조기 난소 부전증 유발 관련 단백질인 FOXL2의 새로운 결합 단백질 UBE2I의 발견
Discovery of UBE2I as a Novel binding Protein of a Premature Ovarian Failure-Related Protein, FOXL2
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
BPES (Blepharophimosis/ptosis/epicanthus inversus syndrome) is an autosomal dominant disorder caused by mutations in FOXL2. Affected individuals have premature ovarian failure (POF) in addition to small palpebral fissures, drooping eyelids, and broad nasal bridge. FOXL2 is a member of the forkhead family transcription factors. In FOXL2- deficient ovaries, granulosa cell differentiation dose not progress, leading to arrest of folliculogenesis and oocytes atresia. Using yeast two-hybrid screening of rat ovarian cDNA library with FOXL2 as bait, we found that small ubiquitin-related modifier(SUMO)-conjugating E2 enzyme UBE2I protein interacted with FOXL2 protein. UBE2I also known as UBC9 is an essential protein for processing SUMO modification. Sumoylation is a form of post-translational modification involved in diverse signaling pathways including the regulation of transcriptional activities of many transcriptional factors. In the present study, we confirmed the protein-protein interaction between FOXL2 and UBE2I in human cells, 293T, by in vivo immunoprecipitation. In addition, we generated truncated FOXL2 mutants and identified the region of FOXL2 required for its association with UBE2I using yeast-two hybrid system. Therefore, the identification of UBE2I as an interacting protein of FOXL2 further suggests a presence of novel regulatory mechanism of FOXL2 by sumoylation
Abstract
BPES (Blepharophimosis/ptosis/epicanthus inversus syndrome) is an autosomal dominant disorder caused by mutations in FOXL2. Affected individuals have premature ovarian failure (POF) in addition to small palpebral fissures, drooping eyelids, and broad nasal bridge. FOXL2 is a member of the forkhead family transcription factors. In FOXL2- deficient ovaries, granulosa cell differentiation dose not progress, leading to arrest of folliculogenesis and oocytes atresia. Using yeast two-hybrid screening of rat ovarian cDNA library with FOXL2 as bait, we found that small ubiquitin-related modifier(SUMO)-conjugating E2 enzyme UBE2I protein interacted with FOXL2 protein. UBE2I also known as UBC9 is an essential protein for processing SUMO modification. Sumoylation is a form of post-translational modification involved in diverse signaling pathways including the regulation of transcriptional activities of many transcriptional factors. In the present study, we confirmed the protein-protein interaction between FOXL2 and UBE2I in human cells, 293T, by in vivo immunoprecipitation. In addition, we generated truncated FOXL2 mutants and identified the region of FOXL2 required for its association with UBE2I using yeast-two hybrid system. Therefore, the identification of UBE2I as an interacting protein of FOXL2 further suggests a presence of novel regulatory mechanism of FOXL2 by sumoylation
참고문헌 (16)
- Anckar J, "SUMO: Getting it on", Biochem Soc Trans, 35, pp.1409~1413 (2007)
- Batista F, "Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics", Proc Natl Acad Sci USA, 104, pp.3330~3335 (2007)
- Beysen D, "The human FOXL2 mutation database", Hum Mutat, 24, pp.189~193 (2004)
- De Baere E, "Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation", Hum Mol Genet, 10, pp.1591~1600 (2001)
- Dohmen RJ, "SUMO protein modification", Biochim Biophys Acta, 1695, pp.113~131 (2004)
- Hoek A, "Premature ovarian failure and ovarian autoimmunity", Endocr Rev, 18, pp.107~134 (1997)
- Ihara M, "UBE2I (UBC9), a SUMO-conjugating enzyme, localizes to nuclear speckles and stimulates transcription in mouse oocytes", Biol Reprod, 79, pp.906~913 (2008)
- Kaestner KH, "Unified nomenclature for the winged helix", forkhead transcription factors, 2000, pp.14, 142~146
- Lee K, "Transcriptional factor FOXL2 interacts with DP103 and induces apoptosis", Biochem Biophys Res Commun, 336, pp.876~881 (2005)
- Pannetier M, "FOXL2 activates P450 aromatase gene transcription: towards a better characterization of the early steps of mammalian ovarian development", J Mol Endocrinol, 36, pp.399~413 (2006)
- Pisarska MD, "Forkhead l2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene", Endocrinology, 145, pp.3424~3433 (2004)
- Sapetschnig A, "Transcription factor Sp3 is silenced through SUMO modification by PIAS1", EMBO J, 21, pp.5206~5215 (2002)
- Schmidt D, "The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance", Development, 131, pp.933~942 (2004)
- Uda M, "Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development", Hum Mol Genet, 13, pp.1171~1181 (2004)
- Uhlenhaut NH, "Foxl2 function in ovarian development", Mol Genet Metab, 88, pp.225~234 (2006)
- 김정욱, "조기 난소 부전증(Premature Ovarian Failure, POF) 환자에서 난포 자극 호르몬 수용체 유전자 변이 및 발현 양상에 대한 분석", 발생과 생식, 4, pp.61~66 (2000)